Transaction overview

Lehman Pipe and Supply, LLC, a leading distributor of pipe, valves, and fittings in the United States, acquired Cole Industrial on June 24, 2025. While the deal value was not disclosed, the acquisition aims to bolster Lehman's product offerings and inventory management capabilities across various vertical markets, including industrial distribution. The transaction consolidates two industry leaders with complementary strengths and overlapping geographic footprints in Florida.

Deal structure and financing

The equity and debt split for the Cole Industrial acquisition by Lehman Pipe remains undisclosed. Rotunda Capital Partners, which is Lehman Pipe's private equity backer, acted as the buy-side advisor but the sell-side advisory team was not disclosed. Given Lehman Pipe’s history of leveraging to finance acquisitions, it is likely that a portion of the deal value was covered through debt financing from institutional lenders such as banks or mezzanine funds.

Strategic context

Lehman Pipe's acquisition of Cole Industrial underscores its strategy to expand product offerings and inventory availability across diverse vertical markets. The combined entity will leverage Cole’s technical expertise and strong customer relationships in industrial distribution, while benefiting from Lehman’s commercial foundation and logistical capabilities. This merger aligns with both companies' shared commitment to operational excellence and customer service.

Cole Industrial's divestiture of its assets to Lehman Pipe reflects the company's desire to consolidate under a larger platform that can provide greater financial stability and growth opportunities. Michael Torres, former owner of Cole Industrial, cited alignment in values and mutual respect as key reasons for this strategic partnership.

Regulatory path

As both Lehman Pipe and Cole Industrial are based in Florida, U.S., the acquisition likely required review by the Federal Trade Commission (FTC) or the Antitrust Division of the Department of Justice (DOJ). Given the undisclosed nature of the deal value and the absence of specific antitrust concerns reported in the transaction announcement, it is probable that no significant regulatory hurdles were encountered. The companies did not disclose any remedies required to address competition issues, indicating a smooth regulatory approval process.